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Abstract
Background: Tissue Doppler Imaging (TDI) is a sensible and feasible method to detect longitudinal left ventricular
(LV) systolic dysfunction (LVSD) in patients with diabetes mellitus, hypertension or ischemic heart disease. In this
study, we hypothesized that longitudinal LVSD assessed by TDI predicted inducible myocardial ischemia independently
of other echocardiographic variables (assessed as coexisting potential markers) in patients at increased cardiovascular
(CV) risk.
Methods: Two hundred one patients at high CV risk defined according to the ESC Guidelines 2012 underwent exercise
stress echocardiography (ExSEcho) for primary prevention. Echocardiographic parameters were measured at rest and
peak exercise.
Results: ExSEcho classified 168 (83.6 %) patients as non-ischemic and 33 (16,4 %) as ischemic. Baseline clinical
characteristics were similar between the groups, but ischemic had higher blood pressure, received more frequently
beta-blockers and antiplatelet agents than non-ischemic patients. The former had greater LV size, lower relative wall
thickness and higher left atrial systolic force (LASF) than the latter. LV systolic longitudinal function (measure as peak S’)
was significantly lower in ischemic than non-ischemic patients (8.7 ± 2.1 vs 9.7 ± 2.7 cm/sec, p = 0.001). The factors
independently related to myocardial ischemia at multivariate logistic analysis were: lower peak S’, higher LV
circumferential end-systolic stress and LASF.
Conclusions: In asymptomatic patients at increased risk for adverse CV events baseline longitudinal LVSD together
with higher LV circumferential end-systolic stress and LASF were the factors associated with myocardial ischemia
induced by ExSEcho. The assessment of these factors at standard echocardiography might help the physicians for
improving the risk stratification among these patients for ExSEcho.
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Background
Tissue Doppler Imaging (TDI) echocardiography is a
sensible and feasible tool to detect subclinical left ven-
tricular (LV) systolic dysfunction (LVSD). In particular,
the assessment of mitral annular peak systolic velocity
(peak S’) by Tissue-Doppler pulsed wave spectral ana-
lysis, reveals the longitudinal LVSD in several settings of
patients at increased risk for cardiovascular (CV) adverse
events such as those with type 2 diabetes mellitus, arter-
ial hypertension, ischemic heart disease and/or heart
failure with preserved LV ejection fraction (LVEF) [1–7].
As a result, peak S’ has emerged as one of the strongest
predictors for CV disease in the domain of non-invasive
cardiac imaging.
We prospectively studied a large cohort of patients at
increased CV risk without history of cardiac disease to
test the hypothesis that longitudinal LVSD measured as
lower peak S’ at baseline echocardiographic evaluation
can predict inducible myocardial ischemia during exer-
cise stress echocardiography (ExSEcho) in these patients.
Furthermore, we verified whether other echocardio-
graphic parameters were prognosticators of inducible
myocardial ischemia measured at baseline evaluation
preceding ExSEcho.
Methods
Study population
The study patients were consecutively recruited from
the 1st January 2012 to the 31st June 2013 by 2 Italian re-
ferral centers (Trieste and Trento) into a prospective
evaluation and their data collected in the same database.
We selected outpatients aged >18 years without a his-
tory/symptoms of cardiac disease who had an increased
(high or very high) risk of CV events according to the
European Guidelines on Cardiovascular Disease preven-
tion [8]. Patients with a 10-year European SCORE risk >
5 % were considered eligible for this study [8]. At first
visit, participant cardiologists gathered detailed informa-
tion on medical history, laboratory and current drug
therapy. Thus, patients underwent baseline echocardio-
graphic study. Patients with abnormal LV wall motion,
with reduced LVEF, with heart valve disease defined as
more than mild valve regurgitation and/or stenosis of
any degree were also rejected. Finally, patients under-
went ExSEcho. All patients gave written informed con-
sent and Ethical Committees in the two participating
Centers approved the study. The study protocol con-
forms to the ethical guidelines of the Declaration of
Helsinki as revised in 2000.
Echocardiography
Standard transthoracic Doppler echocardiographic stud-
ies were performed using a Megas Esaote Biomedica ma-
chine (Florence, Italy) at Trento, and a GE Vivid 9
machine (at Trieste) both equipped with a 2.5–3.5 MHz
annular array transducer by two experienced cardiolo-
gists (AC, GC) who followed a standardized protocol.
Images were stored on CD or MO disks and forwarded
for final interpretation at the Echocardiography Core
Laboratory at Villa Bianca Hospital of Trento, Italy.
Sonographer (GC) was blinded to clinical data. LV
chamber dimensions and wall thicknesses were mea-
sured by the ASE guidelines [9] and LV mass was calcu-
lated using a validated formula [10]. LV mass was
normalized for height to the 2.7 power and LV hyper-
trophy was defined as LV mass > 49.2 g/m 2.7 for men
and > 46.7 g/m 2.7 for women [11]. Relative wall thick-
ness was calculated as the 2* end-diastolic posterior wall
thickness/LV diameter ratio and indicated concentric LV
geometry if > 0.43 (the 97.5th percentile in a normal
population) [12]. LV end-diastolic and end-systolic
volumes and stroke volume were measured by the bi-
plane method of disks from 2D apical 4 chamber + 2
chamber views and used to calculate LVEF, defined as
reduced if < 50 %. Circumferential end-systolic stress
(CESS) was estimated at the LV midwall from M-
mode tracings using a cylindric model to assess LV
afterload, as previously described [13].
TDI pulsed wave spectral analysis was used to measure
peak S’ (mean of 4 measurements obtained in septal, lat-
eral, inferior and anterior mitral annular position), as an
estimate of longitudinal LV function [1]. Peak S’ <
8.5 cm/sec (corresponding to the 10th percentile distri-
bution of S’ in the reference healthy population previ-
ously analyzed in our center) [5, 6] was considered
indicative of longitudinal LVSD.
Transmitral and pulmonary vein pulsed wave Doppler
curves and early diastolic TDI velocity of mitral annulus
(E’) were assessed according to the ASE recommenda-
tions. Early diastolic velocity of transmitral flow (E) was
divided by E’ and used to classify LV diastolic function
together with other diastolic parameters in 4 degrees as
proposed by Redfield et al. [14]: normal, mild dysfunc-
tion, moderate dysfunction and severe dysfunction. Max-
imal left atrial volume was also computed from 2D
apical 4-chamber view using the area - length method
and was normalized for body surface area. Left atrial sys-
tolic force (LASF) was calculated using a validated
Manning’s equation [15]. Our group in several papers
[16] has reported data on validity, feasibility and repro-
ducibility of LASF.
Exercise stress echocardiography
All patients underwent symptom-limited ExSEcho (semi-
supine position on tilting cycloergometer) with protocol of
25 Watts for 2 minutes workload: heart rate, blood pressure
and 12 lead ECG were recorded at rest and every 2 minutes
of exercise. Echocardiographic data including LV volumes,
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LVEF, mitral Doppler and TDI parameters were measured
at baseline and at the peak exercise. ExSEcho was consid-
ered positive or negative based on symptoms, electrocardio-
graphic and echocardiographic criteria, following the
indications of the international guidelines [17]. According
to the echocardiographic criteria, ExSEcho was defined
positive if wall motion abnormalities developed in at least 1
segment during the stress, while it was defined negative if
wall motion did not change [17]. The threshold of the myo-
cardial ischemia was considered low if manifest at 50 watts,
high if detected at > 100 watts.
Statistical analysis
Data are reported as mean values ±1 standard deviation
(medians and interquartile ranges for variables deviating
from normality) or percentages. Unpaired Student’s test
and χ2 statistics were used for descriptive statistics.
Between-group comparisons of categorical and continu-
ous variables were performed by χ2 test and analysis of
variance (ANOVA) with comparison between each
group by Scheffè test for unequal sample, as appropriate.
The study population was stratified in patients with or
without inducible myocardial ischemia. A multivariable
logistic regression analysis was performed to identify the
variables measured at baseline evaluation independently
related to the development of myocardial ischemia dur-
ing ExSEcho. Variables (systolic blood pressure, peak S’,
CESS, LASF) significantly related to inducible myocar-
dial ischemia at univariate tests (p ≤ 0.01) were included
in the multivariate model; age and gender were forced
into the statistical model. Receiver operating characteris-
tic (ROC) curve analyses were performed to identify the
best cut-off points as the best values for each variable in-
dependently associated with the development of indu-
cible myocardial ischemia. To build a predictive score
for inducible myocardial ischemia, point = 1 was
assigned for each variable outside the predictive cut-off
value. The score ranged from 0 (very low risk) to 3
points (very high risk) for inducible myocardial ischemia.
All analyses were performed using statistical package
SPSS 19.0 (SPSS Inc. Chicago. Illinois) and statistical sig-
nificance was identified by two-tailed p <0.05.
Reproducibility and feasibility of peak S’
Echocardiographic reproducibility of peak S’ was tested on
50 patients of the study cohort and randomly selected. An
expert cardiologist skilled in echocardiography (GC) twice
per each patient analyzed data at baseline, 50 Watts and
peak exercise. The mean difference between two measure-
ments was ± 4 %. SD of this difference was ± 2 %. Bland-
Altman plot showed that in none of these 50 patients the
deviation of values of peak S’ measured twice at two differ-
ent times exceeded the two SD of the mean of peak S’
between the two measures. Inter-observer variability for
peak S’ was tested by comparing these measures with those
acquired by a second sonographer: the mean difference be-
tween two measurements was ± 5 %. SD of this difference
was ± 3 %. Intra and inter-observer variability was excellent
and did not significantly change when peak S’ was mea-
sured at baseline and at peak exercise. Similar data resulted
by the comparison between the two different echo ma-
chines used for this study (Megas Esaote Biomedica and
GE Vivid 9 models). Regarding to the feasibility of peak S’
assessment, no patient had inadequate image quality and
the variable could be assessed in all participants.
Results
Study population
The baseline clinical and echocardiographic characteris-
tics of the 201 participants are shown in the Tables 1
and 2, respectively. Mean age of the study patients was
65 ± 10 years, 32 % were female, near half of them was
affected by hypertension and/or dyslipidemia and/or dia-
betes. In 87 patients (43 %) the risk SCORE was esti-
mated to be very high. At enrollment, patients were
receiving ACE inhibitors and/or angiotensin receptor
blockers (ACE/ARB) in the half of cases and beta-
blockers in about a quarter of cases. LV hypertrophy was
diagnosed in 16 % of the participants, LVSD measured
as impaired S’ was detected in one-fifth and LV diastolic
dysfunction of any degree in about one fourth of them.
Exercise stress echocardiography and ischemic patients
The mean duration of ExSEcho in the total study popula-
tion was 8’55” corresponding to a mean workload of 111 ±
40 watts. According to the results of ExSEcho, patients
were divided into two groups: 168 (84 %) non-ischemic and
33 (16 %) ischemic patients. During ExSEcho, among the
33 patients belonging to the ischemic group, 13 (39 %) suf-
fered from typical chest pain, 24 (73 %) had typical electro-
cardiographic ischemic changes, 28 (85 %) developed
changes in LV wall motion (ipokinesia or akinesia in 17 pa-
tients in the territory of the right coronary artery and 11 in
the left coronary artery). Inducible myocardial ischemia was
diagnosed after a mean time from the beginning of exercise
of 6’50” corresponding to a mean workload of 84 ± 30
watts. The threshold of the myocardial ischemia was low in
10 patients (30 %), high in 7 patients (21 %), and intermedi-
ate in the remaining 16 patients. The baseline clinical and
laboratory characteristics of ischemic and non-ischemic pa-
tients were similar, but systolic blood pressure was signifi-
cantly higher in the former, who were treated more
frequently with beta-blockers and antiplatelet agents, but
less frequently with calcium channel blockers than the lat-
ter (Table 1). At the baseline echocardiography, ischemic
patients had slightly larger LV size, lower relative wall thick-
ness and higher CESS than non-ischemic patients (Table 2).
In the ischemic group, the peak S’ was significantly lower
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and the longitudinal LV function was impaired more fre-
quently (about two-fold) than in the group of non-ischemic
patients. There was no difference in the prevalence of dia-
stolic dysfunction between the two study groups, but LASF
was significantly higher in the group of ischemic patients
(Table 2).
Angiographic data
Invasive coronary angiography was proposed in all 33 is-
chemic patients and performed in 32 of them (one patients
refused the invasive diagnostic test). Three patients (9 %)
had no or minor lesions (less than 30 % diameter stenosis),
2 (6 %) had intermediate lesions (with 30–69 % diameter
stenosis) and 27 (84 %) had significant coronary lesions
(≥70 % diameter stenosis). Among these 27 patients, 20
(74 %) underwent percutaneous transcateter coronary
angioplasty + stent implantation and 7 (26 %) underwent
elective coronary artery by-pass graft surgery.
Predictors of inducible myocardial ischemia
The variables measured at baseline evaluation associ-
ated with the inducible myocardial ischemia at
Table 1 Main clinical characteristics of the 201 study patients, and comparison between the two study sub-groups classified
according to the evidence of myocardial ischemia at the echo exercise test
Variables NO YES p Total study population
(201 patients)Myocardial ischemia
(168 patients, 84 %)
Myocardial ischemia
(33 patients, 16 %)
Age (years) 65 ± 9 66 ± 9 0.50 65 ± 10
Female gender (%) 35 20 0.07 32
Obesity (%) 28 15 0.12 26
Waist circumference (cm) 94 ± 11 93 ± 11 0.16 94 ± 11
Hypertension (%) 46 42 0.72 45
Dyslipidemia (%) 49 45 0.68 48
Active smoker, % 12 12 0.97 12
Diabetes (%) 46 52 0.55 47
Diabetes + hypertension (%) 35 30 0.64 34
Systolic Blood Pressure (mmHg) 140 ± 18 147 ± 23 0.01 141 ± 19
Diastolic Blood Pressure (mmHg) 80 ± 9 81 ± 11 0.35 80 ± 9
Heart Rate (beats/minute) 70 ± 11 67 ± 12 0.11 69 ± 11
Glycemia (mg/dl) 134 ± 59 131 ± 53 0.89 133 ± 58
HbA1c (%) a 7.6 ± 1.4 7.5 ± 1.5 0.88 7.6 ± 1.5
Hemoglobin (gr/dl) 14.3 ± 1.5 14.5 ± 1.5 0.73 14.3 ± 1.5
GFR (ml/min/1.73 m2) 81 ± 8 74 ± 10 0.78 80 ± 24
LDL Cholesterol (mg/dl) 110 [92–132] 95 [81–130] 0.75 106 [83–129]
Triglycerides (mg/dl) 162 [118–218] 145 [89–200] 0.10 157 [99–192]
Macroalbuminuria (>300 mg/g) (%) 22 11 0.47 20
Pharmacological treatment
Betablockers (%) 21 39 0.02 24
ACEi / ARB (%) 46 42 0.67 46
Diuretics (%) 17 18 0.90 17
Calcium antagonists (%) 17 3 0.04 15
Anti-hypertension medications b 1.1 ± 1.1 1.1 ± 1.2 0.95 1.1 ± 1.1
Anti-platelets agents (%) 38 58 0.04 41
Statins (%) 40 45 0.60 41
Metformin (%) a 40 39 0.94 40
Other oral anti-diabetic drugs (%) 20 20 0.97 20
Insulin (%) 16 12 0.70 16
ACEi Angiotensin-converting enzyme inhibitors, ARB Angiotensin T1 receptor blockers, GFR Glomerular Filtration Rate, HbA1c glycated haemoglobin
a Measured in patients with diabetes mellitus only; b number per patient
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univariate analysis were higher systolic blood pressure,
larger LV end-diastolic diameter and end-systolic vol-
ume, lower LV relative wall thickness, higher CESS,
lower peak S’ and higher LASF. At multivariate logistic
regression analysis, higher CESS, lower peak S’ and
higher LASF emerged as the independent conditions
associated with inducible ischemia in the study popu-
lation (Table 3).
Echo score for prediction of inducible ischemia
According to the results of the multivariate regression
analysis, a simple echo score was generated after the
Table 2 Echocardiographic features
Variables NO YES p Total study population
(201 patients)Myocardial ischemia
(168 patients)
Myocardial ischemia
(33 patients)
LV EDD (ml/m2) 2.6 ± 0.3 2.7 ± 0.3 0.02 2.6 ± 0.3
LV ESD (ml/m 2) 1.6 ± 0.3 1.6 ± 0.4 0.46 1.6 ± 0.3
LV EDV (ml/m2) 49 ± 12 51 ± 13 0.45 49 ± 13
LV ESV (ml/m2) 18 ± 5 21 ± 9 0.02 19 ± 6
Relative wall thickness 0.39 ± 0.06 0.36 ± 0.07 0.009 0.38 ± 0.06
Concentric LV geometry (%) 21 10 0.12 19
LV mass index (g/m 2.7) 42 ± 11 40 ± 7 0.40 41 ± 10
LV hypertrophy (%) 16 15 0.89 16
LV stroke volume (ml) 59 ± 19 57 ± 15 0.60 59 ± 18
LV ejection fraction (%) 63 ± 7 60 ± 9 0.06 62 ± 7
LV CESS (dynes/cm2) 120 ± 34 150 ± 53 < 0.001 125 ± 40
Peak S’ (cm/sec) 9.7 ± 1.7 8.7 ± 1.7 0.001 9.6 ± 1.7
Impaired S’ (%) 17 36 0.009 20
Peak E’ (cm/sec) 11.5 ± 2.6 10.8 ± 2.7 0.19 11.4 ± 2.6
E wave of transmitral flow (cm/sec) 70 ± 17 72 ± 23 0.44 70 ± 18
A wave of transmitral flow (cm/sec) 74 ± 18 77 ± 17 0.28 74 ± 18
E / A ratio 0.98 ± 0.29 0.95 ± 0.30 0.60 0.88 ± 0.23
E / E’ ratio 6.4 ± 2.3 7.0 ± 2.7 0.14 6.5 ± 2.3
LV diastolic dysfunction (%) 23 27 0.75 23
Grade I 19 18 35
Grade II 4 9 4
Grade III 0 0 0
Maximal left atrial volume (ml/ m2) 23.4 ± 8.4 22.9 ± 9.0 0.60 23.2 ± 8.6
Left atrial systolic force (Kdynes) 14.5 ± 7.9 17.8 ± 9.7 0.01 15.0 ± 8.3
CESS circumferential end-systolic stress, EDD end-diastolic diameter, EDV end-diastolic volume, ESD end-systolic diameter, ESV end-systolic volume, LV left ventricular, Peak E’
early diastolic Tissue Doppler velocity of mitral annulus, Peak S’ peak mitral annular systolic velocity (Tissue Doppler Imaging), Sc stress corrected
Table 3 Multivariate logistic regression model for prediction of LV myocardial ischemia induced by echo exercise stress
Variables Adjusted OR 95 % CI p
Peak S’ (decrease of 1 cm/sec) 0.71 0.54–0.93 0.01
LV Circumferential End-Systolic Stress (increase 1 dynes/cm2) 1.01 1.00–1.02 0.03
Left atrial systolic force (increase of 1 Kdynes) 1.05 1.01–1.11 0.04
Systolic blood pressure (increase of 1 mmHg) 1.01 0.99–1.04 0.34
Age (years) 1.00 0.95–1.05 0.92
Gender (female) 0.44 0.15–1.33 0.14
Sample size: n = 201
CI Confidence Intervals, LV left Ventricular, OR Odds Ratio, Peak S’ peak mitral annular systolic velocity (Tissue Doppler Imaging), index of LV systolic
longitudinal function
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categorization of the 3 echocardiographic predictors of
inducible myocardial ischemia (see “statistical analysis
paragraph”) as follows: peak S’ (if <10.0 cm/sec = 1 point,
if ≥ 10.0 cm/sec = 0 point); LASF (if >14.0 Kdynes = 1
point, if ≤ 14.0 Kdynes = 0 point); CESS (if >124.0 = 1
point, if ≤ 124.0 dynes/cm2 = 0 point). The identification
of the best cut-off points as the best values for each vari-
able independently associated with the development of
inducible myocardial ischemia was executed by ROC
curve analyses and the results are shown in the Table 4.
The observed event rate (inducible myocardial ischemia)
in the study cohort varied from 5 % to 33 % according
to all possible values derived by the predictive score,
which ranged from 0 to 3 (Fig. 1).
Progression of peak S’ and LASF during exercise
During ExSEcho, the peak S’ remained constantly re-
duced in the ischemic patients in comparison with the
non-ischemic ones: the increase in peak S’ was 25 % in
ischemic and 46 % in non-ischemic patients (p < 0.001)
(Fig. 2). Further, LASF was significantly higher at base-
line evaluation in ischemic than non-ischemic patients,
hence it increased much less in the former than in the
latter during exercise, therefore it was significantly lower
in the ischemic than non-ischemic group at the peak ex-
ercise (Fig. 3).
Discussion
The main result emerged by the present study was that
in patients at increased risk for CV events, without his-
tory of cardiac disease, a reduced longitudinal LV systolic
function measured at baseline evaluation was closely as-
sociated with inducible myocardial ischemia during
ExSEcho, independent of the traditional confounding
factors. Furthermore, the coexistence of high CESS and
high LASF with a reduced longitudinal LV systolic func-
tion predicted the development of inducible myocardial
ischemia during ExSEcho in a substantial portion (one
third) of the ischemic patients. This is what does our
study finding add beyond current day ExSEcho. Unex-
pectedly, no clinical or laboratory variable including dia-
betes mellitus, hypertension or renal dysfunction was
associated with inducible ischemia in our population.
Peak S’ reduction was already identified as an early
marker of longitudinal LV systolic dysfunction in
different conditions [2]. Several authors found in dia-
betic patients a 10–20 % reduction of peak S’ [18, 19]
evident either at rest or during ExSEcho in comparison
with controls [18, 20]. Similarly, 10 % of asymptomatic
hypertensive patients showed a reduction of peak S’,
closely correlated with LV hypertrophy and LVSD [21,
22]. Also in patients with coronary artery disease (CAD),
peak S’ at rest was reduced [23, 24], and the reduction
was positively correlated with the severity of CAD [24].
In other studies [23, 25], significant CAD was associated
with higher LV mass, and with several parameters of dia-
stolic and systolic dysfunction. Our results are partially
in line with the previous ones: in our population, indeed,
TDI identified the presence of inducible myocardial is-
chemia by the lower values of peak S’ in ischemic pa-
tients than controls at rest, but all other Doppler
parameters as well as LV mass were not significantly dif-
ferent between the ischemic and non-ischemic groups.
Collectively, our findings clearly indicate that patients
who developed myocardial ischemia during ExSEcho
have an intrinsic and specific LVSD at rest detectable by
measuring the global longitudinal function using TDI
echocardiography. Furthermore, during ExSEcho, the
longitudinal LV function expressed as peak S’ increased
significantly less in ischemic than in non-ischemic ones.
One reason could be that we induced mainly subendo-
cardial ischemia during ExSEcho and at endocardial
layer the longitudinal component of the myocardial fi-
bers shortening is prevalent. Thus, it is not surprising
the association between subendocardial ischemia and re-
duced increase in longitudinal LV systolic function. Evi-
dently, both conditions and their close relationship also
exist at rest, although overt signs/symptoms of subendo-
cardial ischemia are lacking.
In our study population, diabetes, hypertension and
obesity were widely present. Thus, as predictable, these
pathological conditions could not emerge as prognosti-
cators of ExSEcho-induced myocardial ischemia in this
setting of patients. No difference, indeed, existed in clin-
ical characteristics between the two study groups. Some
difference in drug therapy was present at baseline evalu-
ation but no medication significantly influenced the de-
velopment of ischemia during ExSEcho.
Together with longitudinal LVSD, another condition
independently associated with the inducible myocardial
Table 4 Categorization and identification of the best cut-off points of each variable independently associated with the development
of inducible myocardial ischemia: the ROC curve analyses
Variables Cut-off point AUC [95 % CI] Sensitivity Specificity
Peak S’ (cm/sec) 10.0 0.69 [0.60–0.78] 72 % 60 %
LV CESS (Kdynes/cm2) 124.0 0.67 [0.56–0.78] 63 % 60 %
LASF (Kdynes) 14.0 0.61 [0.51–0.72] 63 % 60 %
AUC Area Under the Curve, CESS Circumferential End-Systolic Stress, CI Confidence Intervals, LASF Left Atrial Systolic Force, LV left ventricular, Peak S’ peak mitral
annular systolic velocity (Tissue Doppler Imaging), index of LV systolic longitudinal function
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ischemia was the higher LASF. With increased LV stiff-
ness and reduced LV compliance, LASF increases to pre-
serve LV filling and has to be considered as a sensible
marker of LV diastolic function [25, 26]. Furthermore,
increased LASF is a prognosticator of a higher CV risk
in patients with chronic heart failure with preserved
LVEF [16], hypertension [27] and aortic stenosis [28].
Our findings may be interpreted as the expression of the
inter-dependence between LV systolic and diastolic func-
tion, two active processes requiring energy closely
coupled in the cardiac cycle which exert a mutual nega-
tive influence in presence of excessive LV mass growth
and/or myocardial ischemia [29]. Interestingly, LASF in-
creased much less in ischemic than non-ischemic pa-
tients during the intermediate phase of ExSEcho and it
was significantly lower in the former than in the latter at
the peak exercise. Two reasons may justify this behavior
recognized by our analysis: 1) the development of atrial
ischemia leading to a reduction of systolic atrial per-
formance in ischemic patients 2) the significant increase
in LV filling pressures during exercise in ischemic pa-
tients leading to a reduction of the peak velocity of the
blood at atrial contraction during late diastole despite a
preserved atrial systolic force: this condition actualizes a
reduction of A wave of the trans-mitral flow and conse-
quently, a reduction of LASF values.
Also an increased LV CESS, row index of LV afterload,
was independently associated with inducible myocardial
ischemia in our patients. CESS was studied in patients at
high CV risk, where it was found increased in presence
of hypertension and LV hypertrophy [30]. In our study a
new relation between increased CESS at basal echocardi-
ography and inducible myocardial ischemia was found,
suggesting higher levels of LV afterload a derivative
hemodynamic status of myocardial ischemia or, alterna-
tively, a condition inducing myocardial ischemia. The
available data do not allow us to definitely assess the real
pathophysiological pathway, so that we can only make
speculative inferences about this finding.
Taking one by one the three echocardiographic param-
eters emerged at multivariate regression analysis as
prognosticators of inducible myocardial ischemia (peak
S’, LASF and CESS), the sensibility and specificity for the
event prediction was around 60 %, slightly better for
peak S’. Furthermore, there is significant overlap be-
tween the S’ values between the two study groups,
resulting in a relatively high number of both false posi-
tive and false negative results where S’ value would be
considered as continuous variable. But combining the
three variables together, on the basis of the cut-off got
Fig. 3 Baseline values and progression during exercise stress
echocardiography of left atrial systolic force (LASF) in patients with
and without inducible myocardial ischemia
Fig. 2 Baseline values and progression during exercise stress
echocardiography of peak mitral annular systolic velocity (peak S’) in
patients with and without inducible myocardial ischemia
Fig. 1 The observed rate of inducible myocardial ischemia in the
study patients classified according to all possible values derived by
the predictive echo-score. The event rate was 5 % in the patients at
lowest risk (score 0) and 33 % in the group at highest risk (score 3)
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from ROC analysis, we could better predict inducible
myocardial ischemia during ExSEcho at baseline echo-
cardiography. The echocardiographic methods for the
assessment of these variables are easy and feasible using
standard echocardiography, so that the proposed evalu-
ation can be performed in every echo-Lab without high
technology.
Limitations and strengths of the study
Lacking follow-up data, no prognostic inference in
regards to the detection of longitudinal LVSD in patients
candidate to ExSEcho can be made. Although our statis-
tical models were extensive, some confounders explain-
ing the observed relations could be left out. The tissue
Doppler S’ is an angle dependent measure, so that we
cannot exclude that this aspect may have influenced at
least in part our results. Finally, the analyses did not
consider any parameter of vascular function. Strengths
of our study include the large number of participants
prospectively enrolled, the reliable, appropriate and vali-
dated methods for the assessment of longitudinal LVSD,
LASF and CESS as well as the other numerous echocar-
diographic variables considered in this investigation, the
comprehensive nature of the dataset and the capability
to correct for the most clinically relevant CV risk
factors.
Conclusions
In asymptomatic patients at increased risk for adverse
CV events baseline longitudinal LVSD together with
higher LV circumferential end-systolic stress and LASF
are the factors associated with myocardial ischemia in-
duced by ExSEcho. The assessment of these factors at
standard echocardiography might help the physicians for
improving the risk stratification among these patients
for ExSEcho. This approach could lead to save substan-
tial human and economic resources. The present find-
ings might have an extensive clinical applicability mostly
because ExSEcho has the advantages of its wide avail-
ability, safety, low cost and versatility for the assessment
of inducible myocardial ischemia.
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